{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:13:24Z","timestamp":1788228804874,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015322","name":"National Cancer Center Japan","doi-asserted-by":"publisher","award":["26-A-4"],"award-info":[{"award-number":["26-A-4"]}],"id":[{"id":"10.13039\/100015322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005731","name":"Juntendo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019729","name":"Japan Labour Health and Welfare Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jtcvs.2023.11.025","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:34:33Z","timestamp":1700624073000},"page":"685-696.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Oncological characteristics of epidermal growth factor receptor\u2013mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance"],"prefix":"10.1016","volume":"168","author":[{"given":"Aritoshi","family":"Hattori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takamochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2023.11.025_bib1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","article-title":"A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201)","volume":"6","author":"Suzuki","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jtcvs.2020.01.107","article-title":"Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer","volume":"161","author":"Hattori","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib3","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.cllc.2017.06.020","article-title":"Presence of even a small ground-glass component in lung adenocarcinoma predicts better survival","volume":"19","author":"Berry","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jtcvs.2020.12.089","article-title":"Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer","volume":"163","author":"Watanabe","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtho.2017.11.129","article-title":"Influence of ground glass opacity and the corresponding pathological findings on survival in patients with clinical stage I non-small cell lung cancer","volume":"13","author":"Aokage","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib6","article-title":"Presence of a ground-glass opacity component is the true prognostic determinant in clinical stage I NSCLC","volume":"3","author":"Hamada","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jtho.2018.12.030","article-title":"Lung adenocarcinomas manifesting as radiological part-solid nodules define a special clinical subtype","volume":"14","author":"Ye","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jtho.2018.09.026","article-title":"Distinct clinicopathologic characteristics and prognosis based on the presence of ground glass opacity component in clinical stage IA lung adenocarcinoma","volume":"14","author":"Hattori","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib10","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib11","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1200\/JCO.2005.00.992","article-title":"Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence","volume":"23","author":"Mitsudomi","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib13","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jtcvs.2017.06.062","article-title":"Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma","volume":"154","author":"Takamochi","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.athoracsur.2020.05.041","article-title":"Clinical impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases","volume":"111","author":"Suda","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib15","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.athoracsur.2018.01.052","article-title":"Epidermal growth factor receptor mutation as a risk factor for recurrence in lung adenocarcinoma","volume":"105","author":"Hayasaka","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2017.04.014","article-title":"Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma","volume":"109","author":"Yotsukura","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107354","article-title":"A problem with clinical T factor in the 8th TNM Edition: prognosis and EGFR mutation status of small sized lung cancers with difficulty to measure the diameter of solid component in part-solid tumor","volume":"184","author":"Matsunaga","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lungcan.2021.07.018","article-title":"Prognostic influence of epidermal growth factor receptor mutation and radiological ground glass appearance in patients with early-stage lung adenocarcinoma","volume":"160","author":"Aokage","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jtcvs.2020.05.099","article-title":"Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma","volume":"162","author":"Deng","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ejcts\/ezab481","article-title":"Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features","volume":"61","author":"Hattori","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society International Multidisciplinary Classification of Lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib23","doi-asserted-by":"crossref","unstructured":"Kamigaichi A, Mimae T, Tsubokawa N, Miyata Y, Adachi H, Shimada Y, et al. Risk factors for recurrence of stage I epidermal growth factor receptor mutated lung adenocarcinoma. Ann Thorac Surg. Published online February 2, 2023. https:\/\/doi.org\/10.1016\/j.athoracsur.2023.01.024","DOI":"10.1016\/j.athoracsur.2023.01.024"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib24","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.jtho.2021.07.006","article-title":"Validation of the novel international association for the study of lung cancer grading system for invasive pulmonary adenocarcinoma and association with common driver mutations","volume":"16","author":"Deng","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lungcan.2011.05.021","article-title":"Do all lung adenocarcinomas follow a stepwise progression?","volume":"74","author":"Yatabe","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/annonc\/mdu505","article-title":"Genetic features of pulmonary\u00a0adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth","volume":"26","author":"Kobayashi","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jtcvs.2020.09.120","article-title":"Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase arranged lung adenocarcinoma","volume":"163","author":"Matsuura","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107348","article-title":"Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics","volume":"184","author":"Goto","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lungcan.2015.11.012","article-title":"Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations","volume":"91","author":"Saruwatari","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib30","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMoa2212083","article-title":"Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib32","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1200\/JCO.19.00075","article-title":"Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer (EMERGING-CTONG 1103): a randomized phase II study","volume":"37","author":"Zhong","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib33","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jtcvs.2022.10.056","article-title":"Clinicopathologic\u00a0outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer","volume":"165","author":"Lengel","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.11.025_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jtcvs.2020.02.131","article-title":"Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: a phase II study","volume":"161","author":"Zhang","year":"2021","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522323011029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522323011029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:17:24Z","timestamp":1788225444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522323011029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0022522323011029"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2023.11.025","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncological characteristics of epidermal growth factor receptor\u2013mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2023.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}